Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:15 PM ET 8-K
Nasdaq/NYSE Compliance Notice Medicus Pharma Ltd. MDCX

Medicus Pharma Nasdaq/NYSE Compliance Notice

Medicus Pharma Ltd. regained compliance with Nasdaq's $1.00 minimum bid price requirement after its common shares closed at or above $1.00 for ten consecutive business days. This compliance notice supersedes a delisting determination letter received on October 20, 2026, which had initially triggered a delisting process due to the company's failure to meet the bid price and stockholders' equity requirements.

Counterparty
Nasdaq
5:11 PM ET 8-K
M&A Deal Silver Bow Mining Corp. SBMT

Silver Bow Mining M&A Deal with Montana Goldfields, Inc. and Montana Tunnels Mining, Inc.

Silver Bow Mining Corp. entered into an amendment to its existing asset purchase agreement with Montana Goldfields and Montana Tunnels Mining to update the deal timeline. The amendment extends the 'Outside Date' for the transaction to 60 days following the delivery of audited financial statements and sets a target date of October 31, 2026, for the sellers to produce those financials.

Counterparty
Montana Goldfields, Inc. and Montana Tunnels Mining, Inc.
5:06 PM ET 8-K
Capital Raise Alpine Income Property Trust, Inc. PINE

Alpine Income Property Trust Capital Raise

Alpine Income Property Trust, Inc. announced a preferred stock offering of 189,747 additional shares of its 8.00% Series A Cumulative Redeemable Preferred Stock. In connection with the offering, the company's manager agreed to waive 50% of the base management fee attributable to the new equity proceeds, reducing the fee rate from 1.50% to 0.75% per annum on that capital.

5:05 PM ET 8-K
M&A Deal Transocean Ltd. RIG

Transocean M&A Deal with Valaris Limited

Transocean Ltd. provided a status update on its pending acquisition of Valaris Limited, announcing that the Bermuda Court sanction hearing is scheduled for November 26, 2026. If sanctioned, the company anticipates the business combination will be consummated on or about December 1, 2026, following shareholder meetings on November 24, 2026.

Counterparty
Valaris Limited
5:02 PM ET 8-K
Clinical Trial Data Cumberland Pharmaceuticals Inc CPIX

Cumberland Pharmaceuticals Clinical Trial Data

Cumberland Pharmaceuticals announced top-line results from its Phase 2a ASSIST-SSc clinical trial evaluating oral ifetroban in patients with systemic sclerosis. The study results supported the safety and tolerability of the drug candidate in this rare disease population.

5:01 PM ET 8-K
M&A Deal Valaris Ltd VAL

Valaris M&A Deal with Transocean Ltd.

Valaris Limited provided a status update on its pending merger with Transocean Ltd., announcing that the Bermuda Court sanction hearing is scheduled for November 26, 2026. If the court sanctions the Scheme of Arrangement, the companies anticipate the business combination will be consummated on or about December 1, 2026.

Counterparty
Transocean Ltd.
4:53 PM ET 8-K
Nasdaq/NYSE Compliance Notice ARC Group Securities Acquisition I FJDI

ARC Group Securities Acquisition I Nasdaq/NYSE Compliance Notice

ARC Group Securities Acquisition I received a deficiency notice from Nasdaq because the aggregate market value of its outstanding warrants fell below the $1 million minimum requirement. The company has until December 4, 2026, to submit a plan to regain compliance, which could grant an extension until April 18, 2027. This notice currently only affects the listing of the warrants (FJDIW) and not the company's ordinary shares or units.

Counterparty
Nasdaq
Term
180 days
4:49 PM ET 8-K
M&A Deal Energy Services of America Corp ESOA

Energy Services of America Signs $6.95M M&A Deal with FAMCO, Inc.

Energy Services of America Corporation completed the acquisition of substantially all operating assets of FAMCO, Inc., a West Virginia utility contractor focused on water and sewer infrastructure. The base purchase price was $6.95 million, paid through a combination of cash and Energy Services common stock. The deal expands the company's capabilities and workforce in the water and utility construction markets.

Value
$6.95M
Counterparty
FAMCO, Inc.
4:49 PM ET 8-K
Capacity Expansion Allegiant Travel CO ALGT

Allegiant Travel Capacity Expansion: $720M Investment

Allegiant Travel Company exercised options to purchase six additional Boeing 737-8 aircraft scheduled for delivery in 2028, bringing its total firm orders to 56 aircraft. The list price for the six aircraft exceeds $720 million, though final prices are subject to discounts and escalations. Additionally, the company entered into new multi-year employment agreements with its executive leadership team, including CEO Gregory Anderson and President/CFO Robert Neal.

Value
$720M
Counterparty
The Boeing Company
Term
through 2028
4:37 PM ET 8-K12B
Capital Raise Tcgx Acquisition Corp. II TCXB

Tcgx Acquisition Corp. II Capital Raise of $104M

TCGX Acquisition Corp. II completed its initial public offering of 10,000,000 Class A ordinary shares and a simultaneous private placement of 450,000 shares to its sponsor. The combined transactions generated $104.5 million in gross proceeds, with $100 million placed into a trust account for the benefit of shareholders.

Value
$104M
Counterparty
TCGX Sponsor II, LLC
4:31 PM ET 8-K
Capital Raise Southport Acquisition Corp. II PORT

Southport Acquisition Corp. II Capital Raise of $210M

Southport Acquisition Corp. II reported the final results of its initial public offering (IPO), which generated $210 million in gross proceeds from the sale of 21,000,000 units. Following the partial exercise and subsequent expiration of the underwriters' over-allotment option, the company's sponsor forfeited 666,667 Class B ordinary shares.

Value
$210M
4:31 PM ET 8-K
M&A Deal XCF Global, Inc. SAFX

XCF Global Signs $60M M&A Deal with Air Products Manufacturing LLC

XCF Global, through its subsidiary New Rise Renewables Paramount, LLC, has entered into a definitive agreement to acquire a sustainable aviation fuel (SAF) production facility in Paramount, California from Air Products Manufacturing LLC. The purchase price consists of $10 million in cash at closing plus a $50 million deferred payment due in 36 months. The acquisition adds approximately 50 million annual gallons of production capacity and is strategically located near Los Angeles International Airport.

Value
$60M
Counterparty
Air Products Manufacturing LLC
4:31 PM ET 8-K
Nasdaq/NYSE Compliance Notice Dragonfly Energy Holdings Corp. DFLI

Dragonfly Energy Holdings Nasdaq/NYSE Compliance Notice

Dragonfly Energy Holdings Corp. received an extension from Nasdaq until December 31, 2026, to regain compliance with the minimum stockholders' equity requirement of $2.5 million. The company had previously reported a stockholders' equity deficit of $184,000 for the period ended June 30, 2026. If the company fails to demonstrate compliance by the deadline, its common stock and warrants may be subject to delisting from The Nasdaq Capital Market.

Counterparty
Nasdaq
Term
through Dec 31, 2026
4:31 PM ET 8-K
Nasdaq/NYSE Compliance Notice Alaunos Therapeutics, Inc. TCRT

Alaunos Therapeutics Nasdaq/NYSE Compliance Notice

Alaunos Therapeutics has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2,500,000 following a private placement financing. As a result, the previously scheduled delisting hearing has been cancelled and the company's common stock will continue to trade on The Nasdaq Capital Market.

Counterparty
Nasdaq
4:30 PM ET 8-K
M&A Deal Permian Basin Royalty Trust PBT

Permian Basin Royalty Trust M&A Deal with PBT Land and Minerals, Inc.

Permian Basin Royalty Trust has received a request from SoftVest Advisors and other unit holders to call a special meeting on November 23, 2026, to vote on a proposed business combination. The meeting will consider an amendment to the Trust Indenture to effect the combination with PBT Land and Minerals, Inc. and the adoption of an omnibus incentive plan. The Trustee intends to call the meeting as requested by holders of more than 15% of the outstanding units.

Counterparty
PBT Land and Minerals, Inc.
4:28 PM ET 8-K
M&A Deal House of Doge Inc. HODO

House of Doge Signs $15M M&A Deal with McQueen Labs Inc.

House of Doge Inc. entered into a binding letter of intent to acquire the MCQ Markets technical and token platform and the McQueen microlending business from McQueen Labs Inc. for $15 million. The consideration includes common stock, a new series of non-voting convertible preferred stock, and a promissory note with milestone-contingent payments. Concurrently, the company is contributing certain assets to the newly formed Dogecoin Labs in exchange for a strategic equity stake.

Value
$15M
Counterparty
McQueen Labs Inc.
4:23 PM ET 8-K
M&A Deal Marketaxess Holdings Inc MKTX

Marketaxess Holdings M&A Deal with Intercontinental Exchange, Inc.

MarketAxess Holdings Inc. provided a status update on its pending merger with Intercontinental Exchange, Inc. (ICE), specifically addressing litigation and stockholder demands alleging incomplete disclosures in its proxy statement. To avoid potential delays to the transaction, the company has voluntarily issued supplemental disclosures to moot the legal claims ahead of the stockholder vote scheduled for October 29, 2026.

Counterparty
Intercontinental Exchange, Inc.
4:20 PM ET 8-K
Nasdaq/NYSE Compliance Notice Century Casinos Inc CNTY

Century Casinos Nasdaq/NYSE Compliance Notice

Century Casinos received a deficiency notice from Nasdaq because its Market Value of Listed Securities (MVLS) fell below the $35 million minimum requirement for 30 consecutive business days. The company has 180 calendar days, until April 19, 2027, to regain compliance by maintaining an MVLS of at least $35 million for 10 consecutive business days. The notice has no immediate effect on the listing of the company's common stock.

Counterparty
Nasdaq Stock Market LLC
Term
180 days
4:20 PM ET 8-K
Capital Raise Evernorth Holdings Inc. XRPN

Evernorth Holdings Capital Raise

Evernorth Holdings Inc. entered into a Common Stock Purchase Agreement with CF Principal Investments LLC (Cantor) to establish a committed equity facility. The company has the right to sell up to 5,218,935 shares of Class A common stock to Cantor at 97% of the volume-weighted average price over a 14-month period.

Counterparty
CF Principal Investments LLC
Term
14 months
4:16 PM ET 8-K
Nasdaq/NYSE Compliance Notice Laser Photonics Corp LASE

Laser Photonics Nasdaq/NYSE Compliance Notice

Laser Photonics Corp received a deficiency notice from Nasdaq on October 20, 2026, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has 180 calendar days, until April 19, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for at least 10 consecutive business days.

Counterparty
Nasdaq
Term
180 days
4:14 PM ET 8-K
M&A Deal Unusual Machines, Inc. UMAC

Unusual Machines Signs $52M M&A Deal with DroneNX LLC d/b/a Upgrade Energy

Unusual Machines completed its acquisition of DroneNX LLC (Upgrade Energy), a U.S. manufacturer of high-performance drone batteries and power systems. The total consideration includes $25 million in common stock, $1 million in cash at closing, and a potential $26 million earn-out based on future revenue targets. The deal expands the company's portfolio of NDAA-compliant drone components to include critical battery and power systems.

Value
$52M
Counterparty
DroneNX LLC d/b/a Upgrade Energy
4:12 PM ET 8-K
Capital Raise Arcus Biosciences, Inc. RCUS

Arcus Biosciences Capital Raise of $288M

Arcus Biosciences completed a public offering of 16,428,572 shares of common stock, including the full exercise of the underwriters' option to purchase additional shares. The offering was priced at $17.50 per share, resulting in net proceeds of approximately $269.7 million after fees and expenses.

Value
$288M
Counterparty
Jefferies LLC, Leerink Partners LLC and TD Securities (USA) LLC
4:10 PM ET 8-K
Nasdaq/NYSE Compliance Notice Citius Oncology, Inc. CTOR

Citius Oncology Nasdaq/NYSE Compliance Notice

Citius Oncology received a formal extension from Nasdaq until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. To satisfy the rule, the company's common stock must close at or above $1.00 for at least ten consecutive business days. The stock continues to trade on the Nasdaq Capital Market under the symbol 'CTOR' while the company evaluates options to address the deficiency.

Counterparty
Nasdaq Stock Market LLC
Term
through April 19, 2027
4:10 PM ET 8-K
M&A Deal Melar Acquisition Corp. I MACI

Melar Acquisition Corp. I M&A Deal with Everli Global Inc.

Melar Acquisition Corp. I shareholders approved its proposed business combination with Everli Global Inc., an e-grocery technology and fulfillment platform in Italy. Following the closing, the combined company will operate as Everli Global Holdings Inc. and trade on Nasdaq under the ticker 'EVRL'.

Counterparty
Everli Global Inc.
4:10 PM ET 8-K
Divestiture Jewett Cameron Trading Co Ltd JCTC

Jewett Cameron Trading Co Divestiture to Washington County for $5.9M

Jewett-Cameron Trading Company's subsidiary, JC USA Inc., entered into a definitive agreement to sell its surplus seed property in Hillsboro, Oregon, to Washington County for $5.9 million. The transaction is subject to a 180-day due diligence period and approval by the Washington County Board of Commissioners. Proceeds from the sale will be used to reduce any outstanding amounts under the company's credit facility, though no amounts are currently outstanding.

Value
$5.9M
Counterparty
Washington County
4:08 PM ET 8-K
M&A Deal Novagold Resources Inc NG

Novagold Resources M&A Deal with Paulson Advisers LLC

NOVAGOLD provided a status update on its pending acquisition of the remaining 40% interest in Donlin Gold LLC from Paulson Advisers LLC. The company issued supplemental disclosures to its proxy statement to address demand letters from purported shareholders and avoid potential litigation delays ahead of the November 3, 2026, shareholder vote. Upon completion, NOVAGOLD will increase its ownership in Donlin Gold from 60% to 100% in an all-share transaction.

Counterparty
Paulson Advisers LLC
4:08 PM ET 8-K
M&A Deal Sunrise Realty Trust, Inc. SUNS

Sunrise Realty Trust M&A Deal with Southern Realty Trust Inc.

Sunrise Realty Trust stockholders approved the issuance of approximately 8.46 million shares for its pending merger with Southern Realty Trust Inc. The merger, which has now received approval from both companies' stockholders, is expected to close on November 5, 2026, creating a larger Nasdaq-listed commercial real estate lending platform.

Counterparty
Southern Realty Trust Inc.
4:07 PM ET 8-K
Nasdaq/NYSE Compliance Notice Stem, Inc. STEM

Stem Nasdaq/NYSE Compliance Notice

Stem, Inc. received a non-compliance letter from the NYSE because its average global market capitalization and stockholders' equity both fell below the $50 million minimum requirement over a 30 trading-day period. The company intends to submit a business plan within 45 days detailing how it will regain compliance within the 18-month cure period. The company's common stock will continue to trade on the NYSE during this period, subject to the exchange's acceptance of the plan.

Counterparty
New York Stock Exchange
Term
18 months
4:06 PM ET 8-K
Nasdaq/NYSE Compliance Notice Akebia Therapeutics, Inc. AKBA

Akebia Therapeutics Nasdaq/NYSE Compliance Notice

Akebia Therapeutics received a deficiency notice from Nasdaq because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 19, 2027, to regain compliance, which requires the stock to close at $1.00 or higher for at least 10 consecutive business days. Akebia is evaluating options to cure the deficiency, including a potential reverse stock split.

Counterparty
Nasdaq
Term
180 days
4:06 PM ET 8-K
Clinical Trial Data Macrogenics Inc MGNX

Macrogenics Clinical Trial Data

MacroGenics announced positive interim Phase 1 data for MGC026, a B7-H3-directed antibody-drug conjugate, in patients with advanced solid tumors. The study showed a 27% best overall response rate in heavily pretreated SCCHN patients and a manageable safety profile with no treatment-related discontinuations in that cohort. Based on these results, the company plans to initiate a front-line combination study evaluating MGC026 with pembrolizumab.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.